COMMUNIQUÉS West-GlobeNewswire

Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9, 2018
04/05/2018
SANTA BARBARA, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its first quarter 2018 [...]
Oncolytics Biotech® Announces Voting Results from its Annual General Meeting of Shareholders
04/05/2018
CALGARY, Alberta and SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Novo Nordisk A/S - Share repurchase programme
04/05/2018
Bagsværd, Denmark, 4 May 2018 - As part of the up to DKK 14 billion 2018 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an amount of up to DKK 2.7 billion in [...]
Novo Nordisk A/S purchases B shares worth DKK 1,038 million from Novo Holdings A/S under the 2018 share repurchase programme
04/05/2018
Bagsværd, Denmark, 4 May 2018 - Novo Nordisk A/S has today entered into an agreement to purchase 3,415,895 B shares (nominal DKK 0.20) of a value of DKK 1,038 million from Novo Holdings A/S. This transaction is part of [...]
British Columbia Psychological Association opposes the classification of psychological and psychiatric conditions as “minor injuries” in ICBC legislation
04/05/2018
VANCOUVER, British Columbia, May 04, 2018 (GLOBE NEWSWIRE) -- The British Columbia Psychological Association opposes the inclusion of “a psychological or psychiatric condition” in the definition of “minor injury” in [...]
CellaVision AB: Bulletin from AGM held on May 4, 2018
04/05/2018
Press release 4 May 2018 Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 4, 2018 At CellaVision's Annual General Meeting, held in Lund today, May 4, 2018, The meeting resolved upon the [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2018
04/05/2018
Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018
04/05/2018
Nombre total de droits de vote et d'actions composant le capital social au 30 avril 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
04/05/2018
EuroPCR Exhibit will Highlight Package-to-Patient Design Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that the Colibri [...]
ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares
04/05/2018
SINGAPORE, May 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (TPEx:6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]
Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time
04/05/2018
SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference
04/05/2018
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, Ph [...]
Celsion Corporation to Hold First Quarter 2018 Financial Results Conference Call on Friday, May 11, 2018
04/05/2018
LAWRENCEVILLE, N.J., May 04, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss financial results for the quarter ended March 31, 2018 and [...]
GBT Announces New Employment Inducement Grants
04/05/2018
SOUTH SAN FRANCISCO, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that on May 1, 2018, the compensation committee of the Company’s board of directors [...]
Verona Pharma to Present at Bio€quity Europe 2018
04/05/2018
LONDON, May 04, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Tetra BioPharma Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001
04/05/2018
OTTAWA, May 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V: TBP ) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for [...]
Genocea to Host First Quarter 2018 Financial Results Conference Call & Webcast on May 10, 2018 at 9 a.m. ET
04/05/2018
CAMBRIDGE, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. ( NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a conference call and [...]
Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9
04/05/2018
EMERYVILLE, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Capricor Therapeutics to Present First Quarter 2018 Financial Results and Corporate Update on May 10
04/05/2018
LOS ANGELES, May 04, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]

Pages